For: | Coppola N, Onorato L, Pisaturo M, Macera M, Sagnelli C, Martini S, Sagnelli E. Role of occult hepatitis B virus infection in chronic hepatitis C. World J Gastroenterol 2015; 21(42): 11931-11940 [PMID: 26576082 DOI: 10.3748/wjg.v21.i42.11931] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i42/11931.htm |
Number | Citing Articles |
1 |
Dalbir S. Sandhu, Randhir Jesudoss. Viral Hepatitis: Chronic Hepatitis C. 2019; : 109 doi: 10.1007/978-3-030-03757-4_6
|
2 |
Camilla Rodrigues de Almeida Ribeiro, Nathalia Alves Araújo de Almeida, Katrini Guidolini Martinelli, Marcia Amendola Pires, Carlos Eduardo Brandao Mello, José J. Barros, Vanessa Salete de Paula. Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients. Virology Journal 2021; 18(1) doi: 10.1186/s12985-021-01487-2
|
3 |
Ekram W. Abd El‐Wahab, Mohammed Metwally, Nesma Lotfy. Effectiveness of hepatitis B vaccination in chronic HCV patients after successful generic direct acting antiviral therapy: significance of isolated hepatitis B core antibodies. Tropical Medicine & International Health 2021; 26(8): 882 doi: 10.1111/tmi.13588
|
4 |
Gizachew Beykaso, Andargachew Mulu, Mirutse Giday, Nega Berhe, Markos Selamu, Dawit Hailu, Tilahun Teklehaymanot. Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia. Infection and Drug Resistance 2022; : 619 doi: 10.2147/IDR.S344668
|
5 |
Nicola Coppola, Lorenzo Onorato, Marta Panella, Giorgio de Stefano, Nicola Mosca, Carmine Minichini, Vincenzo Messina, Nicoletta Potenza, Mario Starace, Loredana Alessio, Nunzia Farella, Evangelista Sagnelli, Aniello Russo. Correlation Between the Hepatic Expression of Human MicroRNA hsa-miR-125a-5p and the Progression of Fibrosis in Patients With Overt and Occult HBV Infection. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01334
|
6 |
Li-Bo Yan, Hui-Ying Rao, Yuan-Ji Ma, Lang Bai, En-Qiang Chen, Ling-Yao Du, Rui-Feng Yang, Lai Wei, Hong Tang. Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study. BMJ Open 2016; 6(10): e012016 doi: 10.1136/bmjopen-2016-012016
|
7 |
C. M. Preda, C. P. Popescu, C. Baicus, I. Constantinescu, A. Oproiu, T. Voiosu, M. Diculescu, L. Negreanu, L. Gheorghe, I. Sporea, A. Trifan, E. Ceausu, D. Proca, M. Manuc. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus‐co‐infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin. Journal of Viral Hepatitis 2018; 25(7): 834 doi: 10.1111/jvh.12872
|
8 |
E. V. Esaulenko, K. E. Novak, V. V. Basina, A. A. Dzemova, R. A. Ganchenko. Prevalence of comorbidity in chronic HCV‑infection. Medical alphabet 2021; (1): 66 doi: 10.33667/2078-5631-2021-1-66-70
|
9 |
Nicola Coppola, Lorenzo Onorato, Valentina Iodice, Mario Starace, Carmine Minichini, Nunzia Farella, Giulia Liorre, Pietro Filippini, Evangelista Sagnelli, Giorgio de Stefano. Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study. Oncotarget 2016; 7(38): 62706 doi: 10.18632/oncotarget.10909
|
10 |
Moyra Machado Portilho, Leticia Cancella Nabuco, Cristiane Alves Villela-Nogueira, Carlos Eduardo Brandão-Mello, José Henrique Pilotto, Geane Lopes Flores, Lia Laura Lewis-Ximenez, Elisabeth Lampe, Livia Melo Villar. Detection of occult hepatitis B in serum and oral fluid samples. Memórias do Instituto Oswaldo Cruz 2018; 113(1): 62 doi: 10.1590/0074-02760170071
|
11 |
Marcus M Mücke, Lisa I Backus, Victoria T Mücke, Nicola Coppola, Carmen M Preda, Ming-Lun Yeh, Lydia S Y Tang, Pamela S Belperio, Eleanor M Wilson, Ming-Lung Yu, Stefan Zeuzem, Eva Herrmann, Johannes Vermehren. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2018; 3(3): 172 doi: 10.1016/S2468-1253(18)30002-5
|
12 |
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli, Nicola Coppola. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention. World Journal of Gastroenterology 2019; 25(26): 3299-3312 doi: 10.3748/wjg.v25.i26.3299
|
13 |
Caterina Sagnelli, Evangelista Sagnelli. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factors. World Journal of Clinical Infectious Diseases 2019; 9(2): 11-22 doi: 10.5495/wjcid.v9.i2.11
|
14 |
A. Marrone, N. Capoluongo, C. D'Amore, M. Pisaturo, M. Esposito, S. Guastafierro, I. Siniscalchi, M. Macera, A. Boemio, L. Onorato, L. Rinaldi, C. Minichini, L. E. Adinolfi, E. Sagnelli, L. Mastrullo, N. Coppola. Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy. Journal of Viral Hepatitis 2018; 25(2): 198 doi: 10.1111/jvh.12802
|
15 |
Agatha S. Rosa, Oscar C. Araujo, Flavia Savassi-Ribas, Carlos A. Fernandes, Henrique S. Coelho, Christian Niel, Cristiane A. Villela-Nogueira, Natalia M. Araujo. Prevalence of occult hepatitis B virus infection and Torque teno virus infection and their association with hepatocellular carcinoma in chronic hepatitis C patients. Virus Research 2017; 242: 166 doi: 10.1016/j.virusres.2017.09.022
|
16 |
Nicola Coppola, Carmine Minichini, Mario Starace, Caterina Sagnelli, Evangelista Sagnelli. Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals. Journal of Medical Virology 2016; 88(10): 1659 doi: 10.1002/jmv.24527
|
17 |
Josef Eberle. Hepatitis B — Diagnostisches Update. MMW - Fortschritte der Medizin 2016; 158(6): 60 doi: 10.1007/s15006-016-8006-6
|
18 |
Julio Cesar Rendon, Fabian Cortes-Mancera, Juan Carlos Restrepo-Gutierrez, Sergio Hoyos, Maria-Cristina Navas, Isabelle Chemin. Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia. PLOS ONE 2017; 12(7): e0180447 doi: 10.1371/journal.pone.0180447
|
19 |
L. V. Bezuglova, L. P. Osipova, E. I. Sergeeva, I. V. Deliy, L. E. Tabikhanova, S. V. Netesov, I. G. Netesova. Markers of Viral Hepatitis B in Blood–Plasma Samples of the Indigenous Population of the Far North of Russia. HBV Genotypes and HBsAg Subtypes. Molecular Genetics, Microbiology and Virology 2022; 37(3): 146 doi: 10.3103/S0891416822030041
|
20 |
Suellen dos Reis Araújo, Andreza Pinheiro Malheiros, Vânia Pinto Sarmento, Heloisa Marceliano Nunes, Pedro Eduardo Bonfim Freitas. Molecular investigation of occult hepatitis B virus infection in a reference center in Northern Brazil. The Brazilian Journal of Infectious Diseases 2022; 26(3): 102367 doi: 10.1016/j.bjid.2022.102367
|
21 |
Lorenzo Onorato, Mariantonietta Pisaturo, Clarissa Camaioni, Pierantonio Grimaldi, Alessio Vinicio Codella, Federica Calò, Nicola Coppola. Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases. Journal of Clinical Medicine 2021; 10(21): 5201 doi: 10.3390/jcm10215201
|
22 |
Bodoor Ali Hussen Al-Masoodi, Alariqi Reem, Saleh S. Bahaj, Raja M. Al-Haimi, Hassan A. Al-Shamahy, Nagib Abuasba, Abdu-Raoof Mohammad Al-shawkany, Jay Prakash Prasad Kumal. Prevalence of occult hepatitis B virus infection among patients receiving haemodialysis in Sana'a city. IJID Regions 2022; 5: 141 doi: 10.1016/j.ijregi.2022.09.004
|
23 |
Evangelista Sagnelli, Margherita Macera, Antonio Russo, Nicola Coppola, Caterina Sagnelli. Epidemiological and etiological variations in hepatocellular carcinoma. Infection 2020; 48(1): 7 doi: 10.1007/s15010-019-01345-y
|
24 |
Jiaye Liu, Shaohui Qiu, Jingjing Lu, Bingyu Yan, Yi Feng, Li Li, Guomin Zhang, Fuzhen Wang, Peng He, Xin Fang, Zhongyu Hu, Xiaofeng Liang, Aiqiang Xu, Li Zhang. Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China. The Journal of Infectious Diseases 2017; 216(3): 327 doi: 10.1093/infdis/jix295
|
25 |
Newaz Hossain, Bharat Puchakayala, Pushpjeet Kanwar, Siddharth Verma, George Abraham, Zhanna Ivanov, Muhammad Obaid Niaz, Smruti R. Mohanty. Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics. Digestive Diseases and Sciences 2017; 62(11): 3193 doi: 10.1007/s10620-017-4754-0
|
26 |
Mohit Mittal, Ke-Qin Hu. Clinical Implications and Management of Chronic Occult Hepatitis B Virus Infection. Current Hepatology Reports 2017; 16(2): 90 doi: 10.1007/s11901-017-0339-9
|
27 |
Khodeir A. Naeima, Abd-El-Samae M. Eman, Aly R. Dina, El-Moatassem M. Ola. Occult hepatitis B virus among patients with chronic hepatitis and hepatocellular carcinoma. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2018; 2(3): 205 doi: 10.4103/sjamf.sjamf_36_18
|
28 |
C. Trigo, P. E. A. A. do Brasil, M. J. M. Costa, L. de Castro. Occult hepatitis B virus infection: clinical implications in tuberculosis treatment. Journal of Viral Hepatitis 2016; 23(12): 1027 doi: 10.1111/jvh.12583
|
29 |
Yutaka Midorikawa, Tadatoshi Takayama, Hisashi Nakayama, Tokio Higaki, Masamichi Moriguchi, Kyoji Moriya, Tatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama. Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1069-y
|
30 |
Robert G. Gish, Syed Abdul Basit, John Ryan, Altaf Dawood, Ulrike Protzer. Hepatitis B Core Antibody: Role in Clinical Practice in 2020. Current Hepatology Reports 2020; 19(3): 254 doi: 10.1007/s11901-020-00522-0
|
31 |
Trang VoPham, Anne Cravero, Lauren D. Feld, Pamela Green, Ziding Feng, Kristin Berry, Nicole J. Kim, Philip Vutien, Jason A. Mendoza, George N. Ioannou. Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis. Cancer Epidemiology, Biomarkers & Prevention 2023; 32(8): 1069 doi: 10.1158/1055-9965.EPI-22-1291
|
32 |
Dorota Zarębska-Michaluk, Robert Flisiak, Marta Flisiak-Jackiewicz. Management of hepatitis B and hepatitis C coinfection: an expert review. Expert Review of Anti-infective Therapy 2020; 18(10): 1033 doi: 10.1080/14787210.2020.1776112
|
33 |
Hiroki Koga, Keita Kai, Shinichi Aishima, Atsushi Kawaguchi, Koutaro Yamaji, Takao Ide, Junji Ueda, Hirokazu Noshiro. Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma. World Journal of Hepatology 2017; 9(35): 1286-1295 doi: 10.4254/wjh.v9.i35.1286
|
34 |
E. A. Bazykina, V. B. Turkutyukov, O. E. Trotsenko, V. O. Kotova, L. A. Balakhontseva, L. V. Butakova, L. V. Varnavskaya, V. V. Fomenko, M. A. Chechulina, A. I. Krapivkin, S. V. Zinkovskaya, G. I. Budai, O. A. Yanovich, E. A. Lomakina, Z. I. Lukina. Prevalence and molecular-genetic characteristics of hepatitis B virus in HIV-positive individuals at the Far Eastern Federal District. Russian Journal of Infection and Immunity 2019; 9(1): 183 doi: 10.15789/2220-7619-2019-1-183-192
|
35 |
Luca Foroghi Biland, Ludovica Ferrari, Vincenzo Malagnino, Elisabetta Teti, Carlotta Cerva, Adele Gentile, Marianna Aragri, Romina Salpini, Valentina Svicher, Massimo Andreoni, Loredana Sarmati. Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report. Journal of Medical Case Reports 2019; 13(1) doi: 10.1186/s13256-019-2232-3
|